Optimizing Psychiatry Change Healthcare Clearinghouse Workflows with Klivira

The Intersection of Psychiatry PA and Clearinghouse Operations

Psychiatry prior authorizations cover a diverse range of services, including atypical antipsychotics, stimulants (controlled), transcranial magnetic stimulation (TMS), and esketamine/ketamine treatments. These often require detailed clinical documentation, which, when submitted manually or via disparate systems, can lead to delays and denials. Integrating these complex requirements with the structured data exchange capabilities of a clearinghouse like Change Healthcare is key to efficiency.

High-Volume Psychiatry Prior Authorization Triggers

• Inpatient psychiatric admission and continued stay, often requiring ASAM Criteria for SUD or InterQual/MCG behavioral criteria.
• Partial hospitalization (PHP) and intensive outpatient (IOP) levels of care.
• Specialty psychiatric medications such as long-acting injectable antipsychotics (e.g., paliperidone palmitate), esketamine (Spravato), brexanolone (Zulresso), and zuranolone (Zurzuvae).
• Electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), typically requiring documentation of failed medication trials.
• Residential treatment for substance use disorder and eating disorders, among the most heavily PA-managed levels of care.
• Specialty drugs for tardive dyskinesia like valbenazine (Ingrezza) and deutetrabenazine (Austedo).

Leveraging Change Healthcare for Psychiatric PA Submissions

As a national clearinghouse, Change Healthcare facilitates critical healthcare transactions, including eligibility (X12 270/271) and prior authorization (X12 278). For psychiatry, this means the potential for standardized electronic submission of PA requests. Klivira's platform automates the generation and submission of HIPAA X12 278 transactions, populating them with the necessary clinical data directly from the EMR, ensuring compliance and reducing manual data entry for psychiatric services.

Key Documentation for Psychiatry PAs via Clearinghouse

• DSM-5-TR diagnoses and severity documentation (PHQ-9, GAD-7, Beck scales) for inpatient and residential admissions.
• ASAM dimension documentation across the six ASAM dimensions for substance use disorder treatment.
• Documentation of failed antidepressant trials (often 2-4 trials) for TMS and ECT.
• Prior oral medication trial documentation for specialty injectables, where applicable.
• REMS documentation for restricted-dispensing drugs like esketamine (Spravato) and brexanolone (Zulresso).

Addressing Psychiatry's Workflow Constraints with Klivira

Psychiatric care often involves time-sensitive admission decisions and continuous concurrent review for inpatient and residential stays. Klivira's platform is designed to handle these specific constraints. Our ASAM-criteria-aware logic and concurrent-review workflow integrate seamlessly with EMR data, enabling rapid generation of X12 278 requests for expedited psychiatric authorizations and continued-stay reviews through the Change Healthcare clearinghouse. This reduces the administrative burden and supports timely patient access to care.

Klivira's Solution for Psychiatry and Change Healthcare Integration

Klivira connects your EMR directly to payers via the Change Healthcare clearinghouse, automating the prior authorization process for complex psychiatric services. Our platform understands the nuances of APA Practice Guidelines and ASAM Criteria, translating clinical evidence into structured data for X12 278 submissions. This integration mitigates common denial reasons like ASAM level mismatch and step therapy, enhancing efficiency and compliance for behavioral health providers.